Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
NGOs Protest Against Novartis' Glivec Lawsuit in India | |
|
| |
Protests marked the annual meeting of Novartis as several NGOs protested against the attempt by the company to obtain a patent for its anti-cancer drug Glivec.
The NGOs said that Novartis' action threatens access to generic drugs in poor countries.
The NGOs said that Novartis' action threatens access to generic drugs in poor countries.
The Berne Declaration, Act Up and Oxfam asked Novartis annual management and shareholders meeting in Basel "to abandon its legal action in India for obtaining a Glivec patent."
"We are asking Novartis once and for all to stop this legal battle in India that is a direct attack on the pharmacy of the developing world," Unni Karunakara, MSF's international president said in a letter to Novartis.
"We will not stand by silently and watch our source of affordable medicines dry up in the future -- we rely on these drugs to do our work in more than 60 countries today."
Forty activists gathered outside the Novartis building, erecting a booth and hoisting banners denouncing Novartis' position.
Glivec generated sales of $4.7 billion (3.5 billion euros) in 2011 and is used in the treatment of chronic myeloid leukemia (blood and bone marrow cancer) as well as against gastrointestinal cancer.
In applying for a patent, "access to cheap medicines would be threatened for the poor in developing countries and emerging economies and India is one of the main suppliers of generic drugs in the world," said Swiss NGO Berne Declaration in a statement.
According to Oxfam, "the price of Novartis' Glivec is 10 times higher than the cost of generic equivalents."
Novartis filed in 2006 a patent application for Glivec in India.
Indian courts rejected the request this year, saying the drug was a new formulation of an existing product.
The Swiss company has appealed to the Supreme Court of India, which has pushed from February to mid-March its hearing on the case, Patrick Durisch, an activist from the Berne Declaration told AFP.
Novartis, contacted by AFP, was not immediately available for comment.
Source-AFP
| |
|
|
More News on: Leukemia, Chronic Myeloid Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
 Comment & Contribute
|
Related Links
Acute Lymphoblastic Leukemia - Causes - Symptoms - Diagnosis - Prognosis
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lymphoblasts. It is the most common of all childhood ...
Acute Myeloid Leukemia-Causes-Symptoms-Diagnosis-Treatment-Prognosis-FAQs
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukemia that affects both children and adults ...
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is considered as one of the 'good ...
Corporate Related News
Esperion Therapeutics Has Raised $33 Million to Finance Clinical Trials
American biotech company Esperion Therapeutics revealed that it has managed to raise $33 million through preferred stock financing which will be used ...
Phase 1 Clinical Trial Reveals Positive Data for BIND Theraputics' Drug for Solid Tumors
Presenting the data at the American Association for Cancer Research (AACR) 2013 Annual Meeting, biopharmaceutical company BIND Therapeutics revealed ...
Cancer Breakthrough Reported by Novogen
Australian drug company Novogen Limited revealed that it has succeeded in isolating the most potent form of its lead anti-cancer drug candidate, ...
Opto Circuits Agrees to Sell Diagnostic Cardiology Products to Mortara Instrument
Mortara Instrument Inc. of Milwaukee has signed an agreement to acquire the cardiac diagnostic product line from Cardiac Science, which is a part of ...
Panacea to Supply Polio Vaccines to Central Government
New Delhi based pharmaceutical company Panacea Biotec revealed that it has signed a deal with the central government to supply more than 345 million ...
Following Pharma Deal, Nestle Ventures into Chinese Medicine
Nestle has announced that it is moving into traditional Chinese medicine by joining forces with Chinese pharma group Chi-Med. The new ...
Medwonders Health Network
- Health News Index
|
|
- News Quick Links
| News Categories: |
| » | Georgian Orthodox Supporters Disrupt Georgia Gay Rights Rally |
| » | Protests Against Berlin's Barbie Dreamhouse |
| » | For Most Women Duchess Kate Is 'Style Icon' |
| » | Fruits and Veggies Could Be Kept Fresh for Longer Period With The Help of New Technology |
| » | Artists Complain That Ban on Wild Animals Brings Down Circus Industry |
| More Life Style News | |
|
Ask an Expert
